Barts Health study looks at how women make choices about surgery to prevent ovarian cancer | Our news

  1. Contrast:

Barts Health study looks at how women make choices about surgery to prevent ovarian cancer

A study by researchers at Barts Health and Queen Mary University of London (QMUL) has investigated how women who are at high risk of ovarian cancer make choices about possible preventive surgery.

Women who have BRCA1 and BRCA2 genetic mutations have between 17-44% lifetime risk of ovarian cancer. Scientists now believe that most ovarian cancers begin in the fallopian tubes, and so women at high risk can choose to undergo surgery to remove both their fallopian tubes and ovaries to reduce their risk.

The 24 women interviewed were participants in the UK PROTECTOR trial, in which removal of tubes as an initial step, and delayed removal of ovaries in a second surgery is being offered as an alternative to standard surgery, which removes both at once.

Standard surgery induces menopause in women who have not yet reached this stage of life.

The proposed alternative two step protocol delays the induced menopause caused by the removal of the ovaries and therefore avoids the side effects of menopause .

The study found that women who were more concerned about cancer risk than about menopause preferred the standard surgery, but those who were more concerned about the detrimental impact of menopause chose the two-step procedure.

Women managed in specialist familial cancer clinic settings felt that they received better quality care than those in non-specialist clinics.

Author Professor Ranjit Manchanda, consultant gynaecological oncologist at The Royal London Hospital, said: “This study shows that a number of women prefer a two-step operation to manage their ovarian cancer risk. It is important for women to be given different options so that they can choose what is best for them.

“Women are happier with their care in specialist family cancer clinics. We need to set up a system for women at higher risk of gynaecological cancers to access such centres, which are able to provide a more streamlined and holistic approach.”  

This work was supported by funding from the Rosetrees Trust and Barts Charity.

Read more


Add a response »

No comments yet: why not be the first to contribute?